Σε εξέλιξη η δίκη στην Αμερική για τις τιμές της ινσουλίνης
Σε εξέλιξη η δίκη στην Αμερική για τις τιμές της ινσουλίνης
Asco-GU 2019 – checkpoint blockers might not be created equal after all
Asco-GU 2019 – checkpoint blockers might not be created equal after all
Merck’s Keytruda Fails in Late-Stage HCC Trial
Merck’s Keytruda Fails in Late-Stage HCC Trial
Why the Most Successful Leaders Don’t Care About Being Liked
Why the Most Successful Leaders Don’t Care About Being Liked
Novo Nordisk Snags FDA Approval for Hemophilia A Treatment
Novo Nordisk Snags FDA Approval for Hemophilia A Treatment
High Dose of Pfizer and Lilly Back Pain Drug Hits the Mark in Phase III Trial
High Dose of Pfizer and Lilly Back Pain Drug Hits the Mark in Phase III Trial
O Alex Gorsky της Johnson & Johnson μιλά για τη συνεργασία με την Apple
O Alex Gorsky της Johnson & Johnson μιλά για τη συνεργασία με την Apple
Deloitte: 2019 Global life sciences outlook report
Deloitte: 2019 Global life sciences outlook report
Deloitte: 2019 Global Life Sciences Outlook report
Deloitte Predicts Pharma Growth Driven by Orphan Disease Drugs and External Deals
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year’s End
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year’s End
Marketing Between Merck and Pfizer, the race is on in kidney cancer—but analysts are calling it early
Marketing
Between Merck and Pfizer, the race is on in kidney cancer—but analysts are calling it early
Inventiva Discontinues Systemic Sclerosis Drug After Mid-Stage Flop
Inventiva Discontinues Systemic Sclerosis Drug After Mid-Stage Flop
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
Keytruda Combination Set to Become a Cornerstone Therapy in Renal Cell Carcinoma
Keytruda Combination Set to Become a Cornerstone Therapy in Renal Cell Carcinoma
«’Αλμα Ζωής»: Δημιουργεί το mobile app “MY alma”
Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! Με οδηγό τις ανάγκες των ασθενών με μεταστατικό καρκίνο μαστού, ο Πανελλήνιος Σύλλογος Γυναικών με … Continue Reading «’Αλμα Ζωής»: Δημιουργεί το mobile app “MY alma”
Asco-GU – Bayer and Orion have their work cut out with darolutamide
Asco-GU – Bayer and Orion have their work cut out with darolutamide
